French biotech firm Nosopharm attracts $2.6 mln
Lyon, France-based Nosopharm, a biotech company focused on researching and developing antimicrobial molecules, has raised $2.6 million in funding. The investors include Auriga Partners, Kreaxi and Alto Invest.
28 March 2017•5 mins read
